US Patent 12090210 Antibody-drug conjugate comprising modified antibody
Patent 12090210 was granted and assigned to Alteogen on September, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 14, 2021
0
Date of Patent
September 17, 2024
0
Patent Applicant
Patent Application Number
17551103
0
Patent Inventor Names
Minsoo Byun
0
Hye-Shin Chung
0
Soon Jae Park
0
Sunbae Lee
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 12090210 Antibody-drug conjugate comprising modified antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.